Waterfront Wealth Inc. Has $222,000 Stock Holdings in Veradigm Inc. (NASDAQ:MDRX)

Waterfront Wealth Inc. cut its position in shares of Veradigm Inc. (NASDAQ:MDRX) by 30.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 21,178 shares of the software maker’s stock after selling 9,084 shares during the quarter. Waterfront Wealth Inc.’s holdings in Veradigm were worth $222,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in MDRX. Louisiana State Employees Retirement System bought a new position in Veradigm during the fourth quarter worth about $574,000. Pacer Advisors Inc. lifted its stake in Veradigm by 108.1% during the fourth quarter. Pacer Advisors Inc. now owns 2,516,574 shares of the software maker’s stock worth $26,399,000 after purchasing an additional 1,307,024 shares during the period. SG Americas Securities LLC bought a new position in Veradigm during the fourth quarter worth about $975,000. Wellington Management Group LLP lifted its stake in Veradigm by 92.5% during the third quarter. Wellington Management Group LLP now owns 2,665,814 shares of the software maker’s stock worth $35,029,000 after purchasing an additional 1,281,319 shares during the period. Finally, American Century Companies Inc. raised its stake in shares of Veradigm by 22.8% in the third quarter. American Century Companies Inc. now owns 95,349 shares of the software maker’s stock valued at $1,253,000 after acquiring an additional 17,680 shares during the last quarter.

Veradigm Stock Performance

Shares of Veradigm stock traded up $0.08 during midday trading on Thursday, reaching $7.63. The company had a trading volume of 39,241 shares, compared to its average volume of 4,025,281. The stock has a fifty day simple moving average of $7.83 and a 200 day simple moving average of $10.18. Veradigm Inc. has a 1-year low of $5.01 and a 1-year high of $14.09.

Wall Street Analyst Weigh In

MDRX has been the subject of a number of research analyst reports. StockNews.com initiated coverage on shares of Veradigm in a research note on Monday. They issued a “hold” rating for the company. Barclays initiated coverage on shares of Veradigm in a research note on Wednesday, January 3rd. They issued an “equal weight” rating and a $11.00 target price for the company. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $10.00 target price (down previously from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th. Finally, Royal Bank of Canada cut their target price on shares of Veradigm from $22.00 to $11.00 and set an “outperform” rating for the company in a research note on Friday, January 19th. Five investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $11.25.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.